Continuously identify and build the differentiated innovative pipeline,
efficiently accelerate the translation of scientific and technological achievements

R&D Introduction

CMS possesses clinically needs-driven capabilities for product identification and project initiation, proven clinical development and commercialization capabilities, and robust cash flow. Building on its core strengths, the Group drives innovation through an “in-house R&D + collaborative R&D” dual-engine model. Focusing on unmet clinical needs, it continuously builds a differentiated specialty innovation pipeline centered on First-in-Class (FIC) and Best-in-Class (BIC) assets, and efficiently advances preclinical research, clinical development, and drug registration—delivering more high-quality pharmaceutical solutions for patients.

*Best-in-class: innovative products with the best efficacy, safety or cost-effectiveness in the class due to their innovative formulations or drug delivery systems

~50

Innovative Pipeline Products

~20

projects have been prepared for/are processing their clinical trials

7 Innovative Drugs

Approved for Marketing in China

*The above data are as at March 16, 2026







Collaborative Development



We expand our differentiated innovation pipeline in mid-to-late clinical stages through industrial investments or strategic collaborations. Leveraging our capabilities and resources, we efficiently advance the clinical development, registration, and commercialization of products in China and other licensed countries/regions, accelerating the implementation of pharmaceutical innovation.






Collaborative Development

In-house R&D

Starting from forward-looking scientific insights and unmet clinical needs, we focus on our advantageous specialty fields, concentrate on novel targets and cutting-edge biotechnologies, and independently advance the entire lifecycle management of innovative drugs to build a proprietary intellectual property pipeline with global influence.




In-house R&D

Pipeline

A broad and differentiated pipeline covering Cardiovascular-Kidney-Metabolic diseases, central nervous system, gastroenterology, ophthalmology, skin health and other specialty fields.

Read more >>

Pipeline